Publication | Open Access

Evaluation of Plasma Urokinase-Type Plasminogen Activator Receptor (UPAR) in Patients With Chronic Hepatitis B, C and Non-Alcoholic Fatty Liver Disease (NAFLD) as Serological Fibrosis Marker

Metabolic SyndromeFibrosisUrologyHepatologyNonalcoholic Fatty Liver DiseaseLiver PhysiologyHepatitisPathologyChronic Hepatitis BLiver DiseaseHepatology FibrosisFatty Liver DiseaseMedicineCirrhosisSerological Fibrosis MarkerHealth Sciences